Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Scherer

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Annals of the Rheumatic Diseases|October 10, 2013
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritisYoann Rombouts, Ewoud Ewing, Lotte A van de Stadt, et al.
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Rheumatology (Oxford, England)|January 18, 2020
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLELaura S van Dam, Zgjim Osmani, Sylvia W A Kamerling, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Annals of the Rheumatic Diseases|August 25, 2017
B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of <i>N</i>-glycosylation sites during somatic hypermutationRochelle D Vergroesen, Linda M Slot, Lise Hafkenscheid, et al.
Rheumatology (Oxford, England)|October 17, 2015
Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosisKai Hang Yiu, Maarten K Ninaber, Lucia J Kroft, et al.
Annals of the Rheumatic Diseases|June 3, 2015
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritisPriscilla F Kerkman, Emeline Fabre, Ellen I H van der Voort, et al.
Rheumatology (Oxford, England)|July 1, 2026
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosisA M Alzahrani, S F H Neys, W M van Oostveen, et al.
Bone Marrow Transplantation|December 8, 2015
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?M C Oliveira, M Labopin, J Henes, et al.
The Lancet. Rheumatology|January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohortsSophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|October 10, 2013
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritisYoann Rombouts, Ewoud Ewing, Lotte A van de Stadt, et al.
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Rheumatology (Oxford, England)|January 18, 2020
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLELaura S van Dam, Zgjim Osmani, Sylvia W A Kamerling, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Annals of the Rheumatic Diseases|August 25, 2017
B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of <i>N</i>-glycosylation sites during somatic hypermutationRochelle D Vergroesen, Linda M Slot, Lise Hafkenscheid, et al.
Rheumatology (Oxford, England)|October 17, 2015
Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosisKai Hang Yiu, Maarten K Ninaber, Lucia J Kroft, et al.
Annals of the Rheumatic Diseases|June 3, 2015
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritisPriscilla F Kerkman, Emeline Fabre, Ellen I H van der Voort, et al.
Rheumatology (Oxford, England)|July 1, 2026
Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosisA M Alzahrani, S F H Neys, W M van Oostveen, et al.
Bone Marrow Transplantation|December 8, 2015
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?M C Oliveira, M Labopin, J Henes, et al.
The Lancet. Rheumatology|January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohortsSophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Pageof 13